Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
1.8125
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.7903
General Information
Revision date
2022-04-26
Product name
KRINTAFEL (TAFENOQUINE) 150MG TABLETS
Product Synonyms
TAFENOQUINE FILM-COATED TABLET * TAFENOQUINE [150MG] FILM-COATED TABLET *
1.2.2. Uses advised against
No other uses are advised
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 1
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H372 Causes damage to organs through prolonged or repeated exposure. H400 Very toxic to aquatic life. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P260 Do not breathe dust. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE/doctor// if you feel unwell. P330 Rinse mouth. P314 Get medical advice/attention if you feel unwell. P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
57.8 % of the mixture consists of component(s) of unknown acute oral toxicity. 81.4125 % of the mixture consists of component(s) of unknown acute dermal toxicity. 81.4125 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 61.1125 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 61.1125 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
